ArticleScientific reports2017

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan.

Tomoyuki Takura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.